Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

JCO precision oncology·2026
Same author

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Nature communications·2026
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

EClinicalMedicine·2026
Same author

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026

関連する実験動画

Updated: May 21, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.1K

腫瘍遺伝子の異常は,メドゥロブラストーマの進行を促し,発症を促さない

Konstantin Okonechnikov1,2,3, Piyush Joshi1,2,3,4, Verena Körber5,6

  • 1Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.

Nature
|May 7, 2025
PubMed
まとめ

グループ3/4の髄芽細胞腫の治療は困難です 単細胞技術では 染色体異常が早期に腫瘍を誘発し MYCのような腫瘍遺伝子は後になって発生し 進行と抵抗を促し 早期診断に役立ちます

さらに関連する動画

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.2K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K

関連する実験動画

Last Updated: May 21, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.1K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.2K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K

科学分野:

  • 小児神経腫瘍学
  • ガンゲノミクス
  • 発達神経生物学

背景:

  • 小児脳腫瘍である 3/4 群の髄芽細胞腫の治療は,重大な腫瘍間異質性によって阻害されています.
  • いくつかの腫瘍には明らかな腫瘍原発があるが,ほとんどの腫瘍は大規模な複製数の偏差を示し,腫瘍の進化と抵抗における腫瘍内異質性および腫瘍原発偏差の役割は十分に理解されていない.

研究 の 目的:

  • 単細胞技術を用いて,染色体異常,腫瘍遺伝子の変異,および腫瘍の進化の相互作用を調査する.
  • 腫瘍性イベントの時間的動態とその治療耐性への影響を理解する.

主な方法:

  • 単核RNA配列解析 (snRNA-seq) と,高通量配列解析 (snATAC-seq) を用いたトランポゼでアクセス可能なクロマチンの単核解析は,3/4群の髄芽細胞瘤サンプルで実施された.
  • 腫瘍サブクローンの空間的分布を分析するために,空間的トランスクリプトミクスを用いた.
  • 集団遺伝学モデルを用いて,髄芽細胞腫の発症時期を推定した.

主要な成果:

  • 大規模な染色体異常は早期の腫瘍発症として特定された.
  • MYC,MYCN,PRDM6の変異のような単一遺伝子の腫瘍発生は,後で発生し,しばしばサブクローナルであることが判明したが,MYCは疾患進行中にクローナルになる.
  • 空間的トランスクリプトミクスは,サブクローンが一般的に散らばっていることを明らかにしましたが,腫瘍内で明確な分離も示することができます.
  • 中枢芽細胞腫の発症は,小脳単極ブラッシュ細胞系において,妊娠の最初の3ヶ月間に発生すると推定された.

結論:

  • 単細胞技術は,3/4群の髄芽細胞腫の複雑な進化の様子を 重要な洞察力として提供します
  • 遺伝的イベントのタイミングとクローンダイナミクスを理解することは,標的治療の開発と治療耐性戦略の改善に不可欠です.
  • これらの発見は,この攻撃的な小児がんの早期発見と診断のための単細胞アプローチの可能性を強調しています.